With the uncertainties around how the COVID-19 situation will develop all businesses, of course, are considering what they feel to be responsible and proportionate courses of action to take to protect themselves and others. One Nucleus is doing likewise, making these judgments in light of UK Government advice in the interests of staff, members and our wider network. To keep our contacts informed, our current view is as follows:
We continue to follow the official UK Government and Public Health England advice and would request all event or training course attendees to do likewise in addition…
Whilst the disruption to business as usual continues due to the pandemic we are acutely aware that for our members maintaining their profile and network engagement is key.
We want to be sure you are aware of the ways you are still able to engage with One Nucleus. Do make the most of your membership, including via the free or discounted digital options we offer.
Events Online:
We continue to run our events online. Over the past year we have evolved the portfolio to include:
BioWednesday Webinars
Innovation Seminars
Conferences
Open Seminars discussing key trends and themes
‘My Question…
Safety equipment including masks, goggles and any kind of PPE can be donated to all hospitals and trust and better coordinated locally. In Cambridge there is coordination efforts from the University coordinating logistics between donators and NHS procurement at Addenbrooke’s Hospital. Contact Jacqui Broker, jb682@medschl.cam.ac.uk.
Further contacts:
Ventilators, to contact ventilators.support@beis.gov.uk
Testing and diagnostics capacity, to contact coviddiagnostics@phe.gov.uk
Innovation and tech, to contact dnhs@nhsx.nhs.uk
All other enquiries or proposals concerning potential…
In these unprecedented times, we at Precision remain resolute in our commitment to supporting the critical work you do. Our goal is to help you continue your cutting edge clinical research without interruption.
Last week, new guidance was for the conduct of clinical trials of medical products in direct response to the COVID 19 pandemic. Unanticipated study challenges include site closures, travel limitation , and supply chain interruptions, all potentially impacting the conduct of clinical trials. This guidance is good news as it provides sponsors
general considerations to assist in assuring…
Cambridge, UK and Dhaka, Bangladesh, 30 March 2020: TTP plc (TTP), a leading independent technology and product development company, has today announced it has entered into a partnership with ME SOLshare Ltd (‘SOLshare’), a social enterprise that has created a new approach to distributing and trading affordable solar electricity across peer-to-peer micro-grids. By making improvements to the SOLbox trading platform, the collaboration aims to increase the supply of sustainable electrical power to communities in developing countries.
SOLshare manages smart peer-to-peer micro-grid systems in…
Reading Scientific Services Ltd (RSSL) has appointed David Ebdon to the newly created role of Senior Group Leader for Biological Sciences. The move comes at a time of growth and expansion for the scientific consultancy, as it continues to strengthen its position as a leading provider of analytical services to the pharmaceutical industry.
Ebdon joins RSSL from Britannia Pharmaceuticals and brings over twenty years’ leadership experience in contract development and manufacturing. With overall responsibility for both the Microbiology and Biomolecular Analysis teams, he is tasked with driving…
26 March 2020
UK Cambridge based technology brokerage company – Link China Pharma Solutions Helped Sareum Sign Global Licensing Deal for its FLT3+Aurora Kinase Inhibitor Programme with a China-based Specialty Pharma Company Sareum Holdings plc (AIM: SAR), the specialist cancer drug discovery and development business, is pleased to announce that it has entered into an agreement (the "Agreement") with a China-based specialty pharmaceutical company (the "Licensee).
Under the terms of the Agreement, the Licensee has been granted an exclusive worldwide licence to develop,…
Life Science SME's, your opportunity to share your business challenges during this turbulent time
MedCity, One Nucleus and SEHTA are working together to support economic growth and development in the health-tech and life science industry. We are looking at ways in which we can offer support to companies to navigate the challenges that we face during this pandemic. In order to understand what the biggest challenges you face are, please spend 5 mins to complete the following survey.Your input through this survey will be used to provide insight to the Greater London Authority (GLA),…
As concerns around the coronavirus continue to grow, RSSL's top priority is to protect the health and welfare of our tutors, our team and our learners.
It is for this reason that we have made the decision to move all of our March, April and May 2020 training courses online.
These LIVE courses will be highly interactive, engaging and have the added benefit of saving learners travel and accommodation costs.
Like all of RSSL's courses, the online courses will be led by a team of dedicated industry professionals with additional learning materials supplied beforehand to ensure that…
Arecor Extends Multi-Product Collaboration with Clinical Stage Biotech
Arecor innovative product formulations applied to oncology and rare orphan diseases
Cambridge, UK, 19 March 2020: Arecor Limited (“Arecor” or “the Company”), the biopharmaceutical company advancing today’s therapies to enable healthier lives, announces that it has extended its multi-product collaboration with a US-based clinical stage biotechnology company. Under the collaboration, Arecor will leverage its Arestat™ technology to develop liquid formulations of two proprietary novel products in oncology and a rare genetic…